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Abstract
Background: To describe the clinical presentation of suprasellar cysts (SSCs) and surgical indications, and compare
the treatment methods of endoscopic ventriculocystostomy (VC) and ventriculocystocisternotomy (VCC).
Methods: We retrospectively reviewed the records of 73 consecutive patients with SSC who were treated between
June 2002 and September 2009. Twenty-two patients were treated with VC and 51 with VCC. Outcome was
assessed by clinical examination and magnetic resonance imaging.
Results: The patients were divided into five groups based on age at presentation: age less than 1 year (n = 6), 1-5
years (n = 36), 6-10 years (n = 15), 11-20 years (n = 11), and 21-53 years (n = 5). The main clinical presentations
were macrocrania (100%), motor deficits (50%), and gaze disturbance (33.3%) in the age less than 1 year group;
macrocrania (75%), motor deficits (63.9%), and gaze disturbance (27.8%) in the 1-5 years group; macrocrania
(46.7%), symptoms of raised intracranial pressure (ICP) (40.0%), endocrine dysfunction (40%), and seizures (33.3%) in
the 6-10 years group; symptoms of raised ICP (54.5%), endocrine dysfunction (54.5%), and reduced visual field or
acuity (36.4%) in the 11-20 years group; and symptoms of raised ICP (80.0%) and reduced visual field or acuity
(40.0%) in the 21-53 years group. The overall success rate of endoscopic fenestration was 90.4%. A Kaplan-Meier
curve for long-term efficacy of the two treatment modalities showed better results for VCC than for VC (p = 0.008).
Conclusions: Different age groups with SSCs have different main clinical presentations. VCC appears to be more
efficacious than VC.
Keywords: Suprasellar cyst clinical presentation, endoscopic fenestration, outcome
Background
Suprasellar cysts (SSCs) are benign developmental collec-
tions of cerebrospinal fluid (CSF). Their presence in
utero and their high prevalence in children who have no
history of trauma support the assumption that they are
congenital [1-3]. Although their true histological nature
is rarely known because their membranes are not often
analyzed histologically, it is reasonable to think that the
majority are arachnoid cysts. Suprasellar cysts constitute
approximately 9% of all arachnoid cysts [4]. These cysts
progressively enlarge from an abnormality in the mem-
brane of Liliequist or in the interpeduncular cistern [5,6].
Typically, SSCs expand fro mt h ep r e p o n t i n es p a c e ,
displacing the floor of the third ventricle upwards, the
pituitary stalk and optic chiasm upwards and forwards,
and the mammillary bodies upwards and backwards. As
the cyst increases in size it fills and occludes the third
ventricle, and distorts and blocks the aqueduct, which
finally results in hydrocephalus.
A suprasellar cyst can be a communicating cyst with a
valve at the penetration of the basilar artery (BA)
through the prepontine arachnoid membrane or be a
noncommunicating cyst [7]. Miyajima et al proposed a
new classification of suprasellar arachnoid cysts: 1) a
noncommunicating intra-arachnoid cyst of the dience-
phalic membrane of Liliequist and 2) a communicating
cyst that is a cystic dilation of the interpeduncular cis-
tern [6]. Intra-arachnoid cysts are noncommunicating,
the basilar bifurcation pushes posteriorly against the
brainstem. Cystic dilation of the interpeduncular cistern
occurs between the two leaves of Liliequist’s membrane;
the basilar bifurcation lies inside the cyst.
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of arachnoid cysts. Shim et al studied 209 patients with
arachnoid cysts and suggested that endoscopic proce-
dures were superior to large craniotomy or shunting,
which are associated with a number of complications
[8]. For patients with a SSC who have hydrocephalus,
endoscopic surgery is the primary treatment. However,
for patients with a SSC who do not have hydrocephalus
the choice of treatment is less clear. Because SSCs are
r a r et h i sh a sp r e v e n t e ds t u d i e sw i t hl a r g en u m b e r so f
patients. Most series have included only a few patients.
For example, Crimmins et al reported on 7 patients
treated with ventriculocystostomy (VC) and 13 patients
with ventriculocystocisternotomy (VCC) [9]. They found
VCC had a higher success rate but the difference was
not statistically significant. Therefore, because of the
lack of data some facets have not been thoroughly char-
acterized. Certain issues remain controversial, including
surgical indications and the type of endoscopic surgery
(VC or VCC).
In this report, we describe a series of 73 patients with
SSCs who were treated at our hospital. The aims of this
study were to determine the peak age of patients with
SSCs at diagnosis, describe the main symptoms of differ-
ent age groups, identify which symptoms can be
improved after surgical treatment and which never
regress, determine the surgical indications, and compare
VC with VCC to assess which endoscopic treatment
method is better.
Methods
Patient population
This retrospective study was approved by the Institu-
tional Review Board of Beijing Tiantan Hospital. The
study included 73 consecutive patients with SSCs who
underwent endoscopic VC (n = 22) or VCC (n = 51)
between June 2002 and September 2009. The patients
were selected for VC or VCC on the basis of the experi-
ence of the neurosurgeons. During the early period the
majority of patients underwent VC but as the neurosur-
geons gained experience over time there was an increase
in the proportion of patients undergoing VCC which is
theoretically considered to be the more reliable proce-
dure. Information obtained from the patients’ records
included age at presentation, symptoms and signs, treat-
ment modalities, postoperative complications, and post-
operative clinical and magnetic resonance imaging
(MRI) evaluations. Patients were excluded if they had a
lateral ventricle that was not large enough for endo-
scopic surgery, had no symptoms, or had previously
undergone shunting.
All of the patients were treated for the first time and
they all had hydrocephalus. Before and after surgery the
patients underwent MRI. Standard T1-weighted axial,
coronal, and sagittal sequences were assessed to establish
the diagnosis of SSC. Because an arachnoid cyst most
closely approximates an ellipsoid shape, we calculated
the cyst volume based on the following formula: volume
=( 4 π/3)(r1)(r2)(r3), with each radius (r) being deter-
mined from the maximal diameter in the anterolateral,
lateral, and vertical planes. The size of the lateral ventri-
cle was estimated using the frontal and occipital horn
width ratio (FOHWR) [10].
Endoscopic Technique
The endoscope was introduced through a point about 3 cm
lateral to the midline and about 1 cm anterior to the coro-
nal suture. As determined on preoperative sagittal MRI,
the position of the point varied according to the anatomy
of the cyst and ventricle so that we could obtain an optimal
trajectory to make the aqueduct visible through the fora-
men of Monro and the endoscope could be inserted along
a trajectory that would enable fenestration of both the
apical and basal cyst membranes with minimal anterior-
posterior manipulation.
Generally, the endoscope was inserted along a line direc-
ted to the imaging line which connected the bilateral
external auditory foramens, but the direction deflected
slightly to the median line to prevent injury to the thala-
mus. After using standard anatomical landmarks to con-
firm visual entry into the right lateral ventricle, the
endoscope was advanced to the foramen of Monro, allow-
ing identification of the bluish-colored apical dome of the
arachnoid cyst (Figure 1A). First, small blood vessels on
the cyst wall were obliterated and a fenestration in its
apical membrane was made using scissors. Second, the
capsule of the cyst was shrunk down with the aid of an
endoscopic bipolar coagulator until the aqueduct was
clearly visible (Figure 1B), which can prevent the persistent
redundant wall of the cyst from free-floating in the third
ventricle. Third, the cyst wall was resected as much as pos-
sible to make a large fenestration in its apical membrane
using scissors (Figure 1C). This completed the VC
procedure.
To perform VCC, the endoscope was advanced into the
cyst, allowing visual inspection of the displaced cisternal
contents (Figure 1D,E,F,G). The endoscope was further
advanced to the basal cyst membrane, where a cystocister-
notomy was performed anterior to the BA (Figure 1H,I).
At this point multiple fenestrations should be made in
avascular portions of the membrane by using blunt biopsy
forceps and scissors between cranial nerves exiting the
brainstem. The fenestrations should be as large as possible
and as many as possible. In some cases, the lower portion
of the cyst formed a relatively flat membrane between the
clivus and the pons, and a second fenestration was easy
and safe to perform. In the cases where the inferior wall of
the cyst extended for some considerable distance and was
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lar artery and the pons, a cystocisternotomy can be per-
formed by making a fenestration against the clivus in the
lower portion of the cyst which is attached to the clivus.
Follow-up evaluation
Postoperatively, patients underwent clinical and MRI eva-
luations. Clinical outcome was recorded as improved,
unchanged, or deteriorated. Clinical improvement was
defined as partial or complete relief of symptoms; deteriora-
tion was defined as a progression of clinical symptoms.
Computed tomography (CT) or MRI of the head was
performed during the first week postoperatively before
discharge. All patients underwent MRI during the fol-
low-up period at 3 and 12 months, and then annually to
compare the pre- and post-fenestration cyst size, ventri-
cle size, and mass effect. Cine-MRI was used in some
patients to look for cerbrospinal fluid (CSF) flow artifact
at the fenestration sites as a demonstration of patency.
A successful operation was defined as improvement in
symptoms and demonstration of the following features
on postoperative MRI (these features can accurately
Figure 1 Intraoperative photographs of the SSC. A: Bluish-colored apical dome of the suprasellar cyst. B: The capsule of the cyst was shrunk
down until the aqueduct was clearly visible. C: A large fenestration was made in the apical membrane of suprasellar cyst. D, E, F, G: The
displaced cisternal contents in the cyst. H, I: Fenestration of the basal cyst membrane. BA = basilar artery; PA = P1 segment of posterior cerebral
artery; PCA = posterior communicating artery; AN = abducent nerve; BM = basal membrane of the arachnoid cyst; P = pons; IS = infundibular
stalk; PG = pituitary gland; CA = carotid artery; D = dorsum sellae; TN = trigeminal nerve; Aqueduct of mesencephalon (red arrow); Fenestration
of the basal membrane of the cyst (black arrows).
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(1) reductions in size of the cysts (Figure 2A,B); (2)
improvement in chiasmatic and mammillary body dis-
tortion and pontine effacement (Figure 3A,B). Changes
in size of the lateral ventricle were used to assess out-
come as a supplementary measure because such changes
are not very clinically significant.
Statistical analysis
Data were presented as mean ± standard deviation or fre-
quencies. The success rates of VC and VCC were com-
pared using a Kaplan-Meier curve for long-term efficacy.
The log-rank test was used to compare long-term efficacy
of the two treatment modalities. Data were analyzed
using SPSS 15.0 software (SPSS, Inc., Chicago, IL, USA).
A p-value < 0.05 was considered statistically significant.
Results
Preoperative evaluation
Among the 73 patients, 39 were male and 34 female.
Age at diagnosis ranged from 6 months to 53 years. The
patients were divided into five groups based on age at
presentation (Table 1): age less than 1 year (n = 6,
8.2%),1-5 years (n = 36, 49.3%),6-10 years (n = 15,
20.5%),11-20 years (n = 11, 15.1%),21-53 years (n = 5,
6.8%). The clinical symptoms and signs at presentation
of each age group are listed in Table 1.
The MRI features found consistently in all patients
included (1) cystic masses with an MRI signal intensity
similar to CSF on all sequences; (2) marked dilatation of
the third and lateral ventricles producing the typical
Mickey Mouse appearance on axial imaging; (3) on
sagittal T1-weighted MR images, the suprasellar cysts
displayed the following three diagnostic MRI features:
vertical displacement of the optic chiasm/tracts; upward
deflection of the rostral mesencephalon and mammillary
bodies; and effacement of the ventral pons.
Postoperative Evaluation
Of the 22 VCs, 18 were effective and 4 failed. In two of
the unsuccessful procedures, treatment failure was
immediately apparent postoperatively. Repeated VCC
was performed after the failure of previous endoscopic
treatments in one patient and the symptoms improved
after the procedure. For the other patient, who had the
preoperative symptom of isolated precocious puberty,
Figure 2 Axial magnetic resonance images obtained in a patient who harbored SSC and hydrocephalus.A :P r e o p e r a t i v ea x i a lT 1 -
weighted image (male, 1 year old). B: Postoperative axial T1-weighted image (25 months later).
Gui et al. BMC Neurology 2011, 11:52
http://www.biomedcentral.com/1471-2377/11/52
Page 4 of 9symptoms did not improve despite a decrease in cyst
volume, and no further surgery was performed. The
other two patients had clinical improvement after sur-
gery, but cyst regrowth and symptoms recurred at 8
months and 1 year, respectively. Both underwent VCC
and the symptoms improved in one patient whereas in
other patient the second endoscopic procedure failed
and the symptoms improved after ventriculoperitoneal
(VP) shunting was performed.
Of the 51 VCCs, 48 were successful and 3 failed. One
patient who had an unsuccessful procedure, had the
symptom of isolated microplasia, and although the cyst
Figure 3 Sagittal magnetic resonance images obtained in same patient. A: Preoperative sagittal T1-weighted image (male, 1 year old) B:
Postoperative sagittal T1-weighted image (25 months later).
Table 1 Symptoms and clinical signs of different age groups
Age less than 1 year (n =
6)
1-5 years
(n = 36)
6-10 years
(n = 15)*
11-20 years
(n = 11)†
21-53 years
(n = 5)
Macrocrania 6 27 7 2 –
Motor deficits 3 23 4 3 1
Microplasia – 34 –
Headache/vomiting/drowsiness 5 6 6 4
Head bobbing 3 2 1 –
Gaze disturbance 2 10 3 ––
Reduced visual field or acuity 5 3 4 2
Seizures 4 5 1 –
Precocious puberty 2 4 3 –
Delayed puberty(primary
amenorrhea)
–– 2 –
* One patient had both microplasia and precocious puberty.
† Two patients with delayed puberty and one patient with precocious puberty also had microplasia.
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patient did not undergo further surgery. Among the
other two patients with unsuccessful procedures, the
treatment failure was immediately apparent postopera-
tively in one and in the other failure was not recognized
until after 15 months of apparently good function. The
symptoms improved after VP shunting in both patients.
Among the 69 patients whose first endoscopic proce-
dure was successful, 21 had symptoms of elevated ICP
(headaches, dizziness, vomiting and drowsiness) and 20
(95.2%) of these patients had improvement of these
symptoms. The improvement rate of motor deficits
(ataxic gait, astasia, tremor of the limbs, etc) was 91.2%
(31/34). Head bobbing improved in all six (100%)
affected patients. Thirteen (92.9%) of 14 of patients who
had symptoms of reduced visual field or acuity had
complete disappearance or marked reduction of these
symptoms. Also, the growth in head circumference
stopped after fenestration in all patients. Ten patients
had epilepsy before surgery; seizures in eight of them
were reduced or disappeared while they were taking oral
anti-epileptic drugs. Preoperative endocrine disorders
(precocious puberty, microplasia and delayed puberty)
and gaze disturbance (ocular bobbing and heterotropia)
did not resolve postoperatively in any patient. Further-
more, five patients who did not have endocrine dysfunc-
tion before surgery developed endocrine dysfunction
during postoperative follow-up (one patient had micro-
plasia, three had precocious puberty, and one had both)
even though they had successful surgery.
In the 69 patients whose first endoscopic procedure was
successful, postoperative MRI demonstrated several fea-
tures that are indicative of effective therapy: (1) The cysts
shrank in all 69 patients; (2) The optic apparatus and
mammillary bodies reoriented to a more horizontal posi-
tion and pontine deformation improved in all 69 patients
(Figure 3A,B); (3) There was neuroimaging evidence of
CSF flow through both the apical and basal fenestrations
s i t e so nc i n em o d eM R I ;( 4 )T h es i z eo ft h ev e n t r i c l e
decreased in 46 patients and stabilized in 23 patients.
Excluding the two patients whose preoperative symp-
toms were isolated endocrine dysfunctions, the VCC
group included 50 patients and 48 had a successful
operation; the VC group included 21 patients and 18 had
a successful operation. The mean follow-up duration was
49.6 ± 25.2 months and 39.4 ± 22.2 months in the VC
and VCC groups, respectively. A Kaplan-Meier curve for
long-term efficacy of the two treatment modalities
showed better results for VCC than for VC (p = 0.008)
(Figure 4).
There was no mortality or morbidity in our series. Fol-
lowing VCCs there were 13 complications: four transient
episodes of sixth nerve palsy, five subdural fluid collec-
tions (with no symptom and no need for any treatment),
one episode of polydipsia and polyuria (symptoms disap-
peared 15 days after the operation), and three seizure dis-
orders (patients took anti-epileptics orally for 3 months
and there was no recrudescence after drug discontinu-
ance during the follow-up period). Following VCs there
were four complications: one CSF leak requiring a lum-
bar drain for 4 days, one seizure disorder (patients took
anti-epileptics orally for 3 months and there was no
recrudescence after drug discontinuation during the fol-
low-up period) and two subdural fluid collections (with
no symptom and no need for any treatment).
Discussion
Age group and symptoms
We found that in infants, the main clinical presenting
symptoms were macrocrania and motor deficits. In chil-
dren and adolescents, the main presenting symptoms were
elevated ICP, endocrine dysfunction, and reduced visual
field or acuity. In adults, the main presenting symptom
was elevated ICP. These age-related findings should be
useful in the clinical setting for diagnosis of SSCs. We also
found that a higher proportion of our patients were male
(53%). Pierre-Kahn et al also reported a male preponder-
ance in patients with SSCs, but the proportion was higher
(61%) [7].
Methods of diagnosis
Suprasellar cysts can mimic a dilated third ventricle and
can be misdiagnosed on CT scans as aqueduct stenosis.
Figure 4 Kaplan-Meier curve for long-term cumulative survival.
VC = ventriculocystostomy; VCC = ventriculocystocisternotomy.
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which is the key to diagnosing SSCs. Wang et al
reported that on MRI, SSCs have three characteristic
features: vertical displacement of the optic chiasm/tracts,
upward displacement of the mammillary bodies, and
ventral pontine displacement [11]. These findings differ
from those of noncommunicating hydrocephalus caused
by aqueduct stenosis in which the mammillary bodies
and the third ventricular floor are inferiorly displaced.
Surgical indications
There is controversy about whether large but asympto-
matic SSCs require surgery and which symptoms indicate
that surgery is needed. With regard to asymptomatic
SSCs, regardless of their size, if they do not evolve they
do not need treatment. We found one case of SSC which
disappeared spontaneously during follow-up, and other
authors have also reported that suprasellar cysts may dis-
appear spontaneously [12,13]. A possible mechanism for
SSC resolution is the formation of a communication
between the cyst and the ventricle or basal cistern
because of a tearing of a weakened cyst wall or a widen-
ing of the slit-valve-like arachnoid membrane around the
basilar artery may occur prior to the disappearance of the
SCC [13]. Most of the cysts found during the prenatal
period decreased in size, disappeared completely, or sta-
bilized without associated clinical deficits during follow-
up [2,9]. Therefore, a conservative approach should be
chosen if a child with a cyst has no symptoms, is neurolo-
gically intact, and undergoes close clinical and radiologi-
cal observation [7,9,14].
In our series, symptoms of elevated ICP, motor deficits,
head bobbing, and reduced visual field or acuity all
improved in patients who underwent surgery which was
successful, but endocrine disorders and gaze disturbance
never regressed. The lack of improvement in gaze distur-
bance is in contrast to the usual finding that sixth nerve
palsy usually improves after treatment for hydrocephalus.
It may be that when cranial nerve paralysis is caused by
intracranial hypertension that improvement is likely after
treatment but when the paralysis is related to SSCs the
paralysis is often caused by direct compression and there-
fore the paralysis involves a different mechanism than
that involved with intracranial hypertension and the
recovery rate of eye movement disorders following sur-
gery is relatively poor. Our finding that gaze disturbance
did not regress following treatment is consistent with a
report by Erşahin et al that endoscopic treatment of
suprasellar arachnoid cysts failed to improve bilateral
sixth nerve palsy in one patient [15]. There were five
patients in our study who had endocrine dysfunction
during postoperative follow-up despite successful sur-
gery. This observation has also been reported by other
authors [7,9]. Therefore, with regard to which symptoms
indicate surgery, we would argue that surgical indications
should include signs of elevated ICP (including increased
head circumference), motor deficits, head bobbing, and
reduced visual field or acuity. Only six patients in our
study had head bobbing. However, three cases have been
reported in the literature of patients with bobble-head
syndrome who have been successfully treated with endo-
scopic surgery for suprasellar arachnoid cysts providing
additional evidence that head bobbing is an indication for
surgery [16,17]. Also, surgery is indicated by progressive
enlargement of the cyst even if patients are asympto-
matic. Contraindications to surgery include the absence
of symptoms and isolated endocrine dysfunction or gaze
disturbance. In addition, it is a common observation that
behavioral difficulties and mental retardation never
regress postoperatively [9]. Most arachnoid cysts that
involve the interpeduncular cistern would be classified as
supracellar cysts, however, some may be pure interpe-
duncular cysts [18]. Such pure interpeduncular cysts tend
to remain stable over time and therefore a conservative
treatment strategy has been recommended [18].
Choice of surgical procedure
Suprasellar cysts can be divided into two types: with
hydrocephalus or without hydrocephalus (Figure 5A,B).
It is rare for a patient with a suprasellar cyst who does
not have hydrocephalus to need surgical treatment. The
therapeutic goals are to remove the mass effect of these
cysts by resection, fenestration, or shunting of the cyst
and relieve the hydrocephalus.
Numerous modalities of surgical treatment including
microsurgical excision or fenestration, endoscopic fenes-
tration, shunting of the cyst and/or ventricular system,
and percutaneous ventricle-cystostomy have been used
for the treatment of the SSCs.
For patients without hydrocephalus, an endoscopic
procedure cannot be performed, so there are two treat-
ment choices: shunting of the cyst and/or ventricular
system and microsurgical excision or fenestration of the
cyst. For patients with hydrocephalus, there are three
treatment choices: endoscopic fenestration of the cyst,
shunting of the cyst and/or ventricular system, and
microsurgical excision or fenestration of the cyst.
The direct approach to the cyst for microsurgical exci-
sion or fenestration of the cyst has been performed by
the subfrontal, pterional, transventricular, and transcal-
losal routes [19-22]. This treatment is rather invasive
with more postoperative complications because of the
deep location of these cysts.
The common problems with any shunting procedure,
such as shunt malfunction, infection, and shunt depen-
dency are well known. Also, the success rate of the VP
shunt as a definitive treatment for SSCs is reported to
be only 10% [21].
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scopic fenestration to the forefront of the management
algorithm for SSCs with hydrocephalus and the procedure
has been demonstrated to be safe and effective
[9,11,15,23,24]. An analysis of 23 reviewed series from
1980 to 2007 showed that a good clinical-radiological out-
come was noted in 30 of 38 (79%) patients treated by cra-
niotomy and cyst excision, in 18 of 21 (85.7%) after shunt
of the cyst, in 12 of 15 (80%) after percutaneous ventricle-
cystostomy, and in 92 of 102 (90%) after endoscopic fenes-
tration [24]. More recently, Yadev et al also reported good
results with endoscopic surgery in a series of 12 patients
[25]. In our series, the overall success rate was 90.4%.
Therefore, based on the evidence, we think that endo-
scopic surgery should be the first choice in the manage-
ment of SSCs with hydrocephalus at the present time.
Endoscopy is impractical in the presence of tiny ventri-
cles, so for the patients without hydrocephalus, Crimmins
et al believe that with the advances in microsurgical tech-
niques, open marsupialization of the cyst into the basal
c i s t e r n si sam o r ee f f e c t i v es o l u t i o nt h a ts h o u l db ep r e -
ferred to shunt insertion [9].
Primary endoscopic procedures failed in seven patients
in our series. Considering the frequency of shunt compli-
cations, we would still prefer VCC to shunt implantation
in cases of VC treatment failure. Among the three patients
with endoscopic VCC after VC failure in our series, two
patients had clinical improvement.
In patients with VCC treatment failure, we considered
that the persistence of hydrocephalus in these patients
may have been due to impaired CSF resorption. Therefore,
for such patients, we prefer shunt implantation to repeated
VCC or direct approach to the cyst through craniotomy.
Choice of endoscopic surgical procedure
There are presently three types of endoscopic surgical
procedures: 1)VC, the goal of VC is to establish
communication between the cyst cavity and ventricles;
2) VCC, the goal of VCC is to open the cyst into both
the ventricles and cisterns; 3) endoscopic fenestration of
suprasellar cysts followed by enough shrinkage coagula-
tion of the cysts, this procedure is done after fenestra-
tion between the cyst cavity and ventricles is finished
[26]. Among the three methods, VCC and VC are most
often used, endoscopic fenestration of SSCs followed by
enough shrinkage coagulation of the cysts has only been
reported by one author [26].
Currently, the main controversy is about whether VCC
is preferable to VC alone. Gangemi et al reviewed 176
patients with suprasellar arachnoid cysts treated by dif-
ferent surgical procedures from 23 series reported after
1980 [24]. The endoscopic procedure was VC in 49
patients and VCC in 53. The rate of clinical-radiological
improvement was higher after VCC (94.3%) than after
VC (85.7%). Crimmins et al also found that the failure
rate of VC to be higher than that of VCC [9]. In our ser-
ies, VCC was also more frequently effective (48 of 50)
than VC (18 of 21). We think that there are two reasons
to explain this result: First, the superior fenestration
tends to close, regardless of whether a single or dual
fenestration is performed because stretching of the third
ventricle creates excess tissue that can overlap and seal
the fenestration after the operation. The persistence of
the basal opening, even in the face of secondary closure
of the apical fenestration, allows adequate cyst decom-
pression into the basal cisterns, thus decreasing the risk
of recurrence [27]. Second, chronic midbrain compres-
sion by the SSC may lead to secondary aqueductal occlu-
sion. In this scenario, apical membrane fenestration
alone, although allowing for adequate cyst decompres-
s i o n ,m a yn o tr e s u l ti ne x t r a v e n t r i c u l a rC S Ff l o w .T h e
basal membrane fenestration serves the purpose of allow-
ing trapped fluid to pass into the basal cisterns and
bypass the occluded aqueduct altogether.
Figure 5 Suprasellar cysts without hydrocephalus.
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followed by enough shrinkage coagulation of the cysts,
we think that it is not reliable enough because the
method also cannot solve the problems related to sec-
ondary aqueductal occlusion.
A limitation of the this study was its retrospective
design. Another limitation was the small number of
patients in the youngest and oldest age groups.
Conclusions
Most patients with SSCs at diagnosis are younger than 5
years. Different age groups have different main clinical
presentations. Surgical indications should include signs
of increased ICP, motor deficits, head bobbing, reduced
visual field or acuity, and progressive enlargement of the
cyst even if the patients were asymptomatic. Contraindi-
cations to surgery include the absence of symptoms and
isolated endocrine dysfunction or gaze disturbance.
Endoscopic VCC should be performed as the first surgi-
cal procedure in all cases with hydrocephalus. Patients
who do not improve after the VCC procedure may be
treated by VP shunting.
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